ArticleAAPS PharmSciTech2023

Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis.

Sonia Verma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.